Mark Casey

Mr. Casey is Executive Vice President and Chief Legal Officer with responsibility for legal affairs, including Novavax’s patent portfolio, transactional and contractual matters, and public securities filings. Additionally, Mr. Casey serves as Corporate Secretary. He has 25 years of legal experience in the life sciences sector including expertise in international business, acquisitions and divestitures, intellectual property, regulatory and legal strategy.  

Mr. Casey has served as Chief Legal Officer and Corporate Secretary at Bryn Pharma, LLC, Mallinckrodt Pharmaceuticals, Idera Pharmaceuticals (now Aceragen). Earlier in his career Mr. Casey served in legal roles of increasing responsibility with Cytc Corporation (acquired by Hologic), Boston Scientific Corp., EMC Corporation and Digital Equipment Corporation. Mr. Casey holds a Bachelor of Science degree in Electrical Engineering from Syracuse University and a Juris Doctor degree from Suffolk University Law School. He is also a registered patent attorney.